Jasper Therapeutics Stock
Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning and therapeutic
Sign up today and learn more about Jasper Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Jasper Therapeutics Stock
Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
Co-Founder & Vice President Operations & Program Management
Co-Founder & Member Board of Directors
Judith Shizuru M.D.